ABSTRACT -Family, twin and segregation analysis have provided evidences that genetic factors are implicated in the susceptibility for obsessive-compulsive disorder (OCD). Several lines of research suggest that the dopaminergic system may be involved in the pathophysiology of OCD. Thus, the aim of the present study was to investigate a possible association between a polymorphism located in intron 8 of the dopamine transporter gene (SLC6A3) and OCD in a Brazilian sample composed by 208 patients and 865 healthy controls. No statistically differences were observed in allelic and genotype distributions between cases and controls. No association was also observed when the sample was divided according to specific phenotypic features such as gender, presence of tic disorders co-morbidity and age at onset of obsessive-compulsive symptoms (OCS). Our results suggest that the intron 8 VNTR of the SLC6A3 investigated in this study is not related to the susceptibility for OCD in our Brazilian sample.
Obsessive-compulsive disorder (OCD) is a common and heterogeneous neuropsychiatric disorder characterized by obsessions (intrusive and recurrent thoughts, images or impulses) and compulsions (repetitive behaviors or mental acts usually performed to relive obsessions). OCD prevalence ranges from 2 to 3% in general population and it has approximately equal sex distributions, but men tend to have an earlier age at onset of obsessive-compulsive symptoms (OCS) comparing to women 1, 2 . Although the etiol-ogy of the disorder remains unknown, twin, family and segregation analysis have provided great evidence that OCD has a strong genetic component 3, 4 . Twin studies have found a concordance of 63-87% among monozygotic twin pairs and 22-47% among dizygotic twin pairs 5 and family studies have shown an increased prevalence of OCD among fi rst-degree relatives of patients with OCD, suggesting that the risk for the development of the disorder is 3-12 times greater when compared to the prevalence among first-degree relatives of control subjects [6] [7] [8] . Segregation analysis have suggested evidence of a possible major dominant or co-dominant model of transmission for OCD, but these studies are not conclusive yet 8 . Several lines of evidence suggest that the dopaminergic system may be involved in the pathophysiology of OCD. For instance, neuroimaging studies have revealed abnormalities in brain regions densely endowed with dopaminergic terminals, such as the basal ganglia. In some studies, Dopamine D2 receptor binding potential is decreased 9 and dopamine transporter binding potential is up-regulated in the basal ganglia of OCD patients which is compatible with the hypothesis of an enhanced dopaminergic activity 10 . In addition, dopamine releasing agents and uptake inhibitors, such as metilfenidate, cocaine, bromocriptine, and bupoprion, exacerbate obsessive-compulsive symptoms (OCS) in OCD patients 11 . Finally, the addition of dopaminergic antagonists has shown effi cacy on treatment of refractory OCD patients, especially those with tic disorders (i.e., chronic motor or vocal tics or Tourette syndrome (TS) co-morbidity 12 . Following the hypothesis of the role of dopaminergic system in OCD, numerous studies have been investigating genetic polymorphisms related to this neurotransmitter. The most commonly dopamine transporter gene (SLC6A3) polymorphism studied in OCD is a 40-bp variable-number tandem repeat (VNTR) located in the 3'UTR region which has repeated copies ranging from 3 to 11, however the results have failed to associate this VNTR polymorphism with OCD [13] [14] [15] . In this way, in the present study we tested a possible association of another SLC6A3 polymorphism, a 30bp VNTR located in intron 8 of this gene, with OCD, which was not previously investigated in patients with this disorder.
METHOD
Sample -Two hundred and eight (male=131-63%; female=77-37%) Brazilian OCD outpatients were recruited at the Institute of Psychiatry, Hospital das Clínicas, University of São Paulo Medical School. Diagnosis of OCD was established according to DSM-IV criteria, using the Structured Clinical Interview for DSM-IV (SCID) 16 , supplemented with additional modules based on DSM-IV criteria for tic disorders (i.e., chronic motor or vocal tics or TS) (available upon request). A total of 865 (male=589-68.1%; female=276-31.9%) healthy control subjects were selected from unrelated subjects admitted to the Blood Donation Center of the Fundação Pró-Sangue of the University of São Paulo Medical School.
We defi ned "age at onset of OCS" in the present study as the age that the patient, or a family member, remembered as the beginning of the OCS. There is no agreement in the literature about the age threshold for defi ning "early onset" in OCD patients 17 . We selected a threshold of age 10 for the early onset group and age 17 for the late onset group. These thresholds are consistent with results form OCD genetic family studies 3, 8 , suggesting a higher morbidity risk to fi rst-degree family members of early-onset probands for OCD (≤10 years) 3 , compared to the fi rst degree family members of probands with later onsets 8 . All patients and control subjects provided written informed consent for taking blood samples. Ethical approval for the study was obtained from the Ethics Committee at the Hospital das Clínicas, University of São Paulo Medical School (CAPPesq).
DNA extraction -Blood samples (10 mL) were collected from all participants and DNA was extracted from leukocytes using the salting out protocol 18 .
Genotyping -Polymerase chain reaction (PCR) was carried out using: 20 ng of genomic DNA, 25 mM MgCl 2, 10 pmol of each specifi c primer (F: 5'-GCTTGGGGAAGGAAGGG-3' AND R: 5'-TGTGTGCGTGCATGTGG-3'), 200 μM dNTP, 5 U/ μL Taq DNA Polymerase and 1x buffer in 10 μL reactions. The PCR conditions were: 95°C for 5 min. followed by 40 cycles (95°C for 45s, 63°C for 45s and 72°C for 45s) and a fi nal extension at 72°C for 6 min. PCR products were separated on 2% agarose gels stained with ethidium bromide and viewed under UV light. The primers used were previously described in Guindalini et al. 19 . To avoid errors, genotyping was read by two independently trained research technicians. When a disagreement arose the genotyping was repeated.
Statistical analysis -Allelic and genotypic distributions of the SLC6A3 polymorphism were compared between 208 patients and 865 controls. We also performed analysis for gender, presence of tic disorders co-morbidity and for age at onset of OCS. Statistical Clump v.1.9 software 20 was used for the analysis. This program generates p values based on Monte Carlo simulations, in which repeated simulations are performed in order to achieve signifi cant levels with more accuracy. This program also produces another p value by collapsing columns with small expected values into one group to establish a new two-to-two table, maximizing the chi-squared value and producing more conservative results. A test for deviations from the Hardy-Weinberg equilibrium was performed using the HWE program 21 . For all statistic tests the level of signifi cance adopted was α<0.05 or 5%.
Obsessive 
RESULTS
No statistical signifi cant differences were observed for the analysis performed in our sample involving the allelic and genotypic distribution between patients and controls (Table 1) . Likewise, no signifi cant results emerged when these groups were divided by gender ( Table 2) .
Presence of tic disorders co-morbidity was investigated in 166 (79.8%) patients of the total sample. Of those 84 (50.6%) has presented this co-morbidity. There was no statistical signifi cant difference involving the allelic and genotypic distribution between OCD patients with tic disorders and patients with no tic disorders (Table 3) . Analysis for age at onset of OCS was performed comparing patients with early onset (age 10 or earlier) and late onset (age 17 or later). In our sample, we had information of age at onset of OCS from 160 (76.9%) patients of the total: 94 (58.8%) had an early onset, 29 (18.1%) a late onset and 37 (23.1%) an intermediate onset of their OCS (age from 11 to 16). We compared patients with early onset (EO) to those with late onset (LO). Again, no association was observed when analysis were performed for these two groups of patients (EO x LO) ( Table 4 ). Obsessive-compulsive disorder: dopamine transporter gene Miguita et al.
As no association was observed when the p values were generated from normal χ 2 test, we considered to verify if collapsed p value could show any association. However no statistical signifi cant differences were observed. Collapsed p values for all analysis are in Table 5 .
DISCUSSION
In order to investigate the hypothesis of the involvement of dopaminergic system in the pathophysiology of OCD, many studies have been conducted with genetic polymorphisms of this system, including the 40-bp VNTR and other polymorphisms related to dopaminergic system such as DRD2, DRD3 and DRD4 22, 23 .
In the present investigation we have tested the association of a VNTR SLC6A3 intron 8 polymorphism and OCD in a sample of 208 OCD patients (131 males and 77 females) and 865 controls (589 males and 276 females). This polymorphism was studied in cocaine abuse and hyperactivity disorder (ADHD) patients showing a positive association with these disorders 19, 24 . However, as far as we know, this is the fi rst association study analyzing this polymorphism in an OCD sample.
According to our analysis, no statistically significant differences were observed in the distribution of allelic and genotypic frequencies between the groups of patients and controls. Taking in consideration the data suggesting that OCD is a heterogeneous disorders 25 we have also repeated our analyses dividing our sample according the current most important variables in the defi nition of OCD subtypes 26 . Therefore, patients and controls were investigated by gender, as some studies suggest differences in clinical manifestation of OCD according to the gender of the patients 27, 28 . Likewise, the samples were also studied in order to verify if the investigated polymorphism could be a risk factor for tic disorders (i.e., chronic motor or vocal tics or TS) co-morbidity with OCD, since the tic-like OCD is one of the most studied OCD subgroup, exhibiting specifi c phenotypic features 29 and particular genetic loading when compared with patients who do not present these symptoms 25, 26 . Finally, we compared the distribution of the frequency of this VNTR polymorphism between OCD patients with early versus late onset of the disorder because patients with early age at onset of OCS have more family history of OCD which suggests a major contribution of genetic factors in the development of the disorder 30 . However we have not found any significant association when the analysis was conducted using these phenotypic variables described above.
A possible limitation of the present study may be related to population stratification, especially because the Brazilian population is not ethnically homogeneous, so the power to detect association may be reduced. Nevertheless, the fact that our samples are in Hardy-Weinberg equilibrium indicates that population stratifi cation problems may not represent an important confounding factor in our study 31 . Moreover, ethnic matching conducted using genetic markers was performed in part of our sample in a case-control study with cocaine dependence and the results showed that despite the ethnic admixture in Brazil the ethnic stratifi cation was not a bias in that case 32 .
In conclusion, the results of this study do not provide evidence of association between OCD and the VNTR intron 8 polymorphism of the dopamine transporter gene (SLC6A3) in the studied sample.
